This was a joint lecture for the Chong Hua Hospital Postgraduate Course by OB-infectious disease specialist Dr Helen Madamba and IM-infectious disease specialist Dr Mitzi Chua.
Call Girl Raipur 9873940964 Book Hot And Sexy Girls
Red Hot Infections in Pregnancy
1. What’s RED & HOT:
INFECTIONS in PREGNANCY
Helen Madamba, M.D. M.P.H.-T.M.
Mitzi Marie M. Chua, M.D.
http://www.epid.gov.lk/web/images/pdf/Influenza/Events/pregnant_women.gif
3. Session
Objectives
To determine the optimum
treatment for selected infections
commonly seen in pregnancy
UTI
HIV/AIDS
Hepatitis B infection
Human papillomavirus
Syphilis
To integrate a management
approach based on the current
evidence and local applicability
4. “InfectionPackage”
forPrenatalCare
Routine tests for infections
during prenatal care
Urinalysis, urine culture for
UTI
HIV Counselling and Testing
HBsAg for Hepatitis B infection
Papsmear for Human
papillomavirus
RPR or VDRL for Syphilis
6. Doyouroutinelyorderurine
cultureaspartofprenatalcare?
Question for our OBs in the audience
In ALL pregnant
patients, a urine
specimen should be
carefully collected for
urinalysis and
culturing during the
first prenatal visit or
at 12-16 weeks’ (9th-
17th, preferably 16th
week) gestation.
U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S.
Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008
Jul 1. 149(1)-43-7. [Medline].
7. Impactof
MaternalUTI
totheFetus
Uterine hypoperfusion due to
maternal dehydration, maternal
anemia, and direct bacterial
endotoxin damage to the placental
vasculature fetal cerebral
hypoperfusion
Untreated upper UTIs associations:
Low birth weight
Prematurity; Premature labor
Hypertension; preeclampsia
Maternal anemia
Amnionitis
8. UA–MSCC
With one hand, spread the labia.
With the other hand, use a castile soap–
moistened towelette to wipe the urethral
meatus downward toward the rectum,
then discard the towelette.
Void the initial portion of the bladder
contents into the toilet.
Catch the middle portion of the bladder
contents in the sterile collection
container, while keeping the labia spread
with the first hand.
RED-ytocollect?
10. Acute
Uncomplicated
Cystitis
A 27-year old, G1P0 13 weeks’
AOG, had urinary frequency and
terminal dysuria for 2 days. There
was no fever. There were also no
vaginal discharges.
WhatUTIcategory?
A 27-year old, G1P0 13 weeks’ AOG, had
urinary frequency and terminal dysuria for 2
days. There was no fever. There were also
no vaginal discharges.
Diagnostics
Urine culture/ sensitivity studies
Significant pyuria (UA)
>8 pus cells/mm3 of uncentrifuged urine, OR
>5 pus cells/HPF of centrifuged urine
AND
(+) leukocyte esterase and nitrite test on
dipstick
Strong recommendation, Moderate quality of evidence
12. Asymptomatic
Bacteriuria
A 37-year old G3P2 16 5/7 weeks AOG
had a urine culture growth of >100,000
CFU Escherichia coli.
On review of presentation, patient had no
complaints but culture was ordered by
attending OB after 2 urinalysis samples
showed pyuria.
WhatUTIcategory?
15. Hot‘n
confusing?
ANTIBIOTIC SELECTION
If the patient is clinically responding to the present
treatment, no need to revise the antibiotic if resistance
to the empirically started antibiotic is reported on
urine culture. Adjust antibiotic therapy based on urine
culture results ONLY when there is no improvement in
the clinical signs and symptoms and laboratory results
or when there is worsening of the patient’s condition.
Strong recommendation, Low quality of evidence
MONITORING
Pregnant patients with pyelonephritis, recurrent UTIs,
concurrent gestational DM, concurrent nephrolithiasis
or urolithiasis, and pre- eclampsia, should be
monitored at monthly intervals until delivery to ensure
that urine remains sterile during pregnancy. Strong
recommendation, Low quality of evidence
[NAG] … and monitor every trimester till delivery.
20. Renal
Ultrasound
Unless an anatomic abnormality or
renal disease is suspected, initial
routine imaging studies are not
necessary.
Patients with suspected
pyelonephritis who are not
responsive to appropriate antibiotic
therapy after 48-72 hours should
also undergo imaging.
Willyouorder?
21. Acute
Uncomplicated
Pyelonephritis
The same 30-year old, G2P1 now
30 weeks’ AOG, presented with
fever, no chills. On PE, she had
right costovertebral angle
tenderness.
Urine culture revealed ESBL
Escherichia coli.
Referred to ID; patient covered
with ertapenem
WhatUTIcategory?
22. Prevention
Behavioral
Methods
Avoid baths.
Wipe front-to-back after urinating or
defecating.
Wash hands before using the toilet.
Use washcloths to clean the perineum.
Use liquid soap to prevent colonization
from bar soap.
Clean the urethral meatus first when
bathing.
Thisone’sHOT!
25. Prong 1. Primary prevention of HIV among
women of child-bearing age.
Prong 2. Preventing unintended pregnancies
among women living with HIV.
Prong 3. Preventing HIV transmission among
women living with HIV to her infant.
Prong 4. Providing treatment, care and
support to women living with HIV, their
children and their families.
https://www.hsph.harvard.edu/population/aids/philippines.aids.09.pdf
Preventionof
Motherto Child
Transmissionof
HIVInfection
29. Preliminary Counselling Dialogue
Providers of obstetric care should
inform the patient that an HIV
screening test will be performed as
part of the recommended routine
antenatal package of tests of
infections (HBsAg, RPR/VDRL,
papsmear, urine culture)
POGS Clinical Practice Recommendations on PMTCT
HIVCounselling
andTesting
30. Preliminary Counselling Dialogue
The fact that you are pregnant
is an evidence of unprotected
penetrative sexual contact
which is a mode of
transmission for HIV.
POGS Clinical Practice Recommendations on PMTCT
HIVCounselling
andTesting
31. AdvantagesofOptionB+
Earlier treatment for woman’s health
and avoiding risks of stopping and
starting triple ARVs especially in
settings of high fertility
Simple message to communities
“once ARV started, it is
taken for life.”
POGS Clinical Practice Recommendations on PMTCT
Anti-retroviral
(ARV)Drugs
32. • An elective cesarean
delivery is scheduled at 38
weeks AOG
• Emergency CS is done for
those in labor and with
ruptured membranes <4 hours
unless delivery is imminent
POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015.
Managementof
Delivery
33. Vaginal delivery maybe done
when the risk of maternal to child
transmission is low:
• those who had ARV treatment
• HIV viral load <1000 copies/ml
• if with ruptured membranes, the time
elapsed should be <4 hours to
delivery
POGS Clinical Practice Recommendation on PMTCT of HIV Infection. November 2015.
Managementof
Delivery
35. initiate/continue ARV medications
replacement feeding: acceptable,
feasible, affordable, sustainable and
safe (AFASS)
risks, follow up and other options
for replacement feeding
relieve breast engorgement
POGS Clinical Practice Recommendations on PMTCT
InfantFeeding
REDHOTFEEDING!
37. Continue exclusive breastfeeding
Initiate/continue ARV medications
for both mother and patient for as
long as breastfeeding up to two (2)
years
POGS Clinical Practice Recommendations on PMTCT
InfantFeeding
REDHOTFEEDING!
42. Whatdoyou
do?
Additional testing (ALT, HBV
DNA, or imaging for HCC
surveillance if indicated)
Determination of need for antiviral
therapy
Women who meet standard
indications for HBV therapy should
be treated.
43. Getaviralload!
Pregnant women positive for
HBsAg should be tested for hep B
virus deoxyribonucleic acid (HBV
DNA) to guide the use of antiviral
medication to prevent perinatal
transmission.
Red-hotCOST!
45. Theironyof“strengthof
recommendation”
AASLD recommends against the
use of antiviral therapy to reduce
the risk of perinatal transmission
of HBV in HBsAg-positive
pregnant women with an HBV-
DNA level <200,000 IU/mL.
Quality and Certainty of Evidence: Low
Strength of Recommendation: Strong
46. Whatto
give?
The only antivirals studied in
pregnant women are lamivudine,
telbivudine, and tenofovir (TDF).
TDF preferred to minimize the risk
of emergence of viral resistance
during treatment
Red-hotchoices
47. Timing&
Duration
Antiviral therapy started at 28-32
weeks’ gestation in most studies.
Discontinued at time of delivery or
up to 4 weeks postpartum
At time of birth to 3 months
postpartum in most studies
With discontinuation of treatment,
women should be monitored closely
for up to 6 months after delivery for
hepatitis flares & seroconversion.
48. Immune-active
hepatitis
Elevation of ALT >2 the ULN or evidence of
significant histologic disease
ULN for ALT in healthy adults is reported to be
29-33 U/L for males and 19-25 U/L for females. A
ULN for ALT of 35 U/L for males and 25 U/L for
females is recommended to guide management
decisions.
PLUS
Elevated HBV DNA above 2,000 IU/mL
(HBeAg negative) or above 20,000 IU/mL
(HBeAg positive).
Treatment should be based on
recommendations for nonpregnant women.
Butdonotethat–
49. Breastfeeding
NOT contraindicated
Antivirals minimally excreted in
breast milk &unlikely to cause
significant toxicity
Insufficient long-term safety data
in infants born to mothers who
took antiviral agents during
pregnancy and while breastfeeding
HotOtherMatters
50. Wedon’tmiss
this,dowe?
The CDC continues to recommend
hepatitis B vaccination and
hepatitis immune globulin
regardless of birth weight within
12 hours of birth for infants born to
hepatitis B-infected mothers.
Red-hotINTERVENTION
58. HepatitisBvaccine
• Hepatitis B vaccine
may be administered
to a pregnant women
who is otherwise
eligible for it.
• HBsAg-negative
pregnant women not
previously
vaccinated
POGS Clinical Practice Guidelines on Immunization for Filipino Women 2011
60. HPV screening
In 2003, the FDA approved a screening test that
can be done in conjunction with a Pap test to
determine if you have the HPV virus. The HPV
DNA test can detect high risk types of HPV, such
as types 16 and 18, before any abnormal cells can
be detected on the cervix.
This screening is recommended for women over
the age of 30, who are at an increased risk of a
chronic HPV infection turning into pre-cancerous
cells.
Men can carry and transmit the HPV infection
without ever having symptoms. At this time,
there is no test to detect HPV in men.
62. HPV Infection
~100 types of HPV
infection, 40 can infect
genital area
Most sexually active
persons become infected
with HPV at leat once in
their lifetime.
Red-hotMYSTERIES
63. HPV Infection
Oncogenic, high-risk HPV
infection causes most cervical,
penile, vulvar, vaginal, anal
and oropharyngeal cancers
and pre-cancers
Non-oncogenic low-risk HPV
infection causes genital warts
and recurrent respiratory
papillomatosis
Red-hotMYSTERIES
CDC Sexually Transmitted Diseases Guidelines, 2015
64. KeyMessages
forCounselling
Most sexually active people get
HPV at some time in their lives,
although most never know it.
It is not possible to determine
which partner transmitted the
original infection.
Types of HPV that cause genital
warts are different from the types
that cause cancer.
Red-hotMESSAGES
CDC Sexually Transmitted Diseases Guidelines, 2015
65. Special
Considerations
Podofilox, podophyllin,
sinecatechins, imiquimod should
not be used in pregnancy
Anogenital warts can proliferate
and become friable during
pregnancy
Resolution might be incomplete or
poor until pregnancy is complete.
Red-hotMESSAGES
CDC Sexually Transmitted Diseases Guidelines, 2015
66. Managementof
Delivery
Cesarean delivery should not be
performed solely to prevent
transmission of HPV infection to
the newborn
Cesarean delivery is indicated if
pelvic outlet is obstructed or if
vaginal delivery would result in
excessive bleeding.
Low risk for recurrent respiratory
papillomatosis
CDC Sexually Transmitted Diseases Guidelines, 2015
67. Doyouroutinelyscreenfor
HPVaspartofprenatalcare?
Question for our OBs in the audience
Cervical cancer
screening should be
part of routine
prenatal care.
• Papsmear
• Visual inspection
with acetic acid
(VIA)
• HPV testing
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
68. Doyouroutinelyscreenfor
HPVaspartofprenatalcare?
Question for our OBs in the audience
Cervical cancer
screening should be
part of routine
prenatal care.
• Papsmear
• Visual inspection
with acetic acid
(VIA)
• HPV testing
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
69. AmIatriskfor
cervicalcancer?
HPV infection is the necessary cause of
cervical cancer.
Parity of 7 or more
Long-term use of OCPs
Smoking
Co-infection of HPV with Chlamydia
trachomatis or herpes simplex virus
HIV infection
REDflags-risks
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
70. AmIatriskfor
cervicalcancer?
Early age at first intercourse
Lifetime number of sexual partners
Early age at first full term pregnancy
Uncircumcised male partner
No prior screening
Low socioeconomic status
REDflags-risks
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
71. Primary
Preventionof
cervicalcancer
Total abstinence prevents HPV infection.
Lifetime mutual monogamy prevents
HPV infection.
Consistent and correct use of barrier
protection decreases cervical cancer
incidence.
Vaccination against HPV 16/18 is
efficacious against persistent HPV
infection and ≥ CIN 2+.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
72. Secondary
Preventionof
cervicalcancer
Regular gynecologic examinations and
cytologic test (Pap smear) with treatment
of precancerous abnormalities
Liquid based cytology
Visual inspection with acetic acid is an
acceptable alternative to Pap smear.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
73. Secondary
Preventionof
cervicalcancer
Screening should begin approximately 3
years after onset of vaginal intercourse
but not earlier than 21.
Annual screening with conventional
cervical cytology until age 30 years.
At or after age 30 years, a woman who
has had 3 consecutive normal results
may undergo screening ever 2 to 3 years
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
74. Secondary
Preventionof
cervicalcancer
Annual gynecologic examination is
recommended regardless of the frequency
of screening.
Women immunized against HPV 16/18
should be screened same as non-
immunized women.
A pap test should be obtained twice in
the first year after diagnosis of HIV
infection and if results are normal,
annually thereafter.
REDHOTINTERVENTION
Society of Gynecologic Oncologists of the Philippines (Foundation) Inc.
Clinical Practice Guidelines for the Obstetrician-Gynecologist 2010
75. In 2003, the FDA approved a screening test that can be
done in conjunction with a Pap test to determine if you
have the HPV virus. The HPV DNA test can detect
high risk types of HPV, such as types 16 and 18, before
any abnormal cells can be detected on the cervix.
This screening is recommended for women over the age
of 30, who are at an increased risk of a chronic HPV
infection turning into pre-cancerous cells.
Men can carry and transmit the HPV infection without
ever having symptoms. At this time, there is no test to
detect HPV in men.
79. Syphilis
Infection
Primary syphilis infection – ulcers or
chancre at the infection site
Secondary syphilis – skin rash,
mucocutaneous lesions,
lymphadenopathy
Tertiary syphilis – cardiac,
gummatous lesions, tabes dorsalis,
general paresis
Latent syphilis infection – those
lacking manifestations, detected by
serologic testing
Early latent syphilis – acquired within the preceding year
Late latent syphilis – acquired more than a year prior
Syphilis of unknown duration
80. DiagnosticTests
forSyphilis
Darkfield examination from lesion
exudates definitive method for
diagnosing Treponema pallidum
A presumptive diagnosis of
syphilis requires use of two tests:
Nontreponemal test like VDRL
or RPR
Treponemal test like FTA-ABS,
TP-PA, TP-EIA or rapid
treponemal assays
81. SyphilisScreening
• For patients with poor prenatal care, RPR test screening and treatment should
be performed at the time pregnancy is confirmed
• Pregnant women with reactive treponemal screening tests should have
additional quantitative nontreponemal testing to monitor treatment response.
• For women at high risk of infection, serologic testing should be performed
twice, at 28-32 weeks AOG and at delivery
• Any woman with fetal death after 20 weeks AOG should be tested for syphilis.
82. Syphilisduring
Pregnancy
Risk for antepartum fetal infection or
congenital syphilis at delivery is
related to the stage of syphilis during
pregnancy, with the highest risk
occurring with the primary and
secondary stage.
Quantitative maternal nontreponemal
titer, especially if >1:8, might be a
marker of early infection and
bacteremia.
83. SyphilisScreening
•If a treponemal test (e.g., EIA or CIA) is used for antepartum
syphilis screening, all positive EIA/CIA tests should be reflexed to
a quantitative nontreponemal test (RPR or VDRL).
•If the nontreponemal test is negative, then the results are
considered discrepant and a second treponemal test (TP-PA
preferred) should be performed, preferably on the same specimen.
•If the second treponemal test is positive, current or past syphilis
infection can be confirmed.
84. SyphilisScreening
•If the second treponemal test is negative, the positive EIA/CIA is
more likely to represent a false-positive test result in low-risk
women with no history of treated syphilis.
•If the woman is at low risk for syphilis, (-) signs or symptoms,
partner (-) syphilis, and is likely to follow up, repeat serologic testing
within 4 weeks.
•If both the RPR and TP-PA remain negative, no further treatment is
necessary.
•If follow-up is not possible, women without a history of treated
syphilis should be treated according to the stage of syphilis.
85. Preferred
Regimen
Penicillin is the only drug
recommended for treatment of
pregnant women with syphilis.
Pregnant women allergic to penicillin should be desensitized and treated with
penicillin.
Primary, Secondary, Early Latent (<1 year
duration)
1st line: Benzathine penicillin G 2.4MU IM
x 1 dose
Late latent (including unknown duration)
1st line: Benzathine penicillin G 7.2 MU
total, administered as 3 doses of 2.4 MU IM
each buttock at 1-week intervals
86. Management
Pearls
When syphilis is diagnosed during the second
half of pregnancy
Include a sonographic fetal evaluation for
congenital syphilis
Sonographic signs of fetal or placental syphilis
(i.e., hepatomegaly, ascites, hydrops, fetal anemia,
or a thickened placenta) indicate a greater risk for
fetal treatment failure
Women treated for syphilis during the second half
of pregnancy are at risk for premature labor
and/or fetal distress if the treatment precipitates
the Jarisch-Herxheimer reaction.
Advise to seek obstetric attention after treatment
if they notice any fever, contractions, or decrease
in fetal movements.
87. Missed doses are not acceptable for
pregnant women receiving therapy
for late latent syphilis. Pregnant
women who miss any dose of
therapy must repeat the full course
of therapy.
All women who have syphilis
should be offered testing for HIV
infection.
Management
Pearls
U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1. 149(1)-43-7. [Medline].
Maternal UTI has few direct fetal sequelae because fetal bloodstream infection is rare; however, uterine hypoperfusion due to maternal dehydration, maternal anemia, and direct bacterial endotoxin damage to the placental vasculature may cause fetal cerebral hypoperfusion.
Untreated upper UTIs are associated with low birth weight, prematurity, premature labor, hypertension, preeclampsia, maternal anemia, and amnionitis. [12] A retrospective population-based study by Mazor-Dray et al showed that UTI during pregnancy is independently associated with intrauterine growth restriction, preeclampsia, preterm delivery, and cesarean delivery. [9] A prospective cohort study of pregnant patients also suggested an association between maternal UTI and childhood asthma. [13]
Millar and Cox indicate that 1-2 bacteria in an unspun catheterized specimen or more than 20 bacteria per high-power field (HPF) in spun urine correlate closely with bacterial colony counts higher than 100,000 CFU/mL on a urine culture. [18]
Hormonal and mechanical changes can promote urinary stasis and vesicoureteral reflux. These changes, along with an already short urethra (approximately 3-4 cm in females) and difficulty with hygiene due to a distended pregnant belly, help make UTIs among the most common bacterial infections during pregnancy.
In general, pregnant patients are considered immunocompromised UTI hosts because of the physiologic changes associated with pregnancy (see Pathophysiology).
Acute cystitis is complicated by upper urinary tract disease (ie, pyelonephritis) in 15-50% of cases.
NAG: Start empiric antibiotic immediately, but pre-treatment urine must be submitted for culture and susceptibility; adjust treatment accordingly. Document clearance of bacteriuria with a repeat urine culture 1-2 weeks post-treatment. Avoid amoxicillin-clavulanate in those at risk of pre-term labor because of potential for neonatal necrotizing enterocolitis.
Use nitrofurantoin from the 2nd trimester to 32 weeks only, if possible, because of potential for birth defects and hemolytic anemia. Avoid cotrimoxazole especially during the first and third trimesters because of risk of teratogenicity and kernicterus. Fluoroquinolones are contraindicated.
Untreated asymptomatic bacteriuria is a risk factor for acute cystitis (40%) and pyelonephritis (25-30%) in pregnancy. These cases account for 70% of all cases of symptomatic UTI in unscreened pregnant women.
A difference between pregnant and nonpregnant women is that the prevalence of asymptomatic bacteriuria in pregnant women is 2.5-11%, as opposed to 3-8% in nonpregnant women. In as many as 40% of these cases, bacteriuria may progress to symptomatic upper UTI or pyelonephritis; this rate is significantly higher than that seen in nonpregnant women. [4]
Cephalexin 500 mg 4 times daily Ampicillin 500 mg 4 times daily
Nitrofurantoin 100 mg twice daily Sulfisoxazole 1 g 4 times daily
Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5-7 days or
Amoxicillin 500 mg orally twice daily (alternative: 250 mg orally three times daily) for 5-7 days or
Amoxicillin-clavulanate 500/125 mg orally twice daily for 3-7 days (alternative: 250/125 mg orally three times daily for 5-7 days) or
Cephalexin 500 mg orally twice daily for 3-7 days
A test-for-cure urine culture should show negative findings 1-2 weeks after therapy. A nonnegative culture result is an indication for a 10- to 14-day course of a different antibiotic, followed by suppressive therapy (eg, nitrofurantoin 50 mg at bedtime) until 6 weeks postpartum.
Fluoroquinolones are to be used with caution in pregnancy. Both ciprofloxacin and levofloxacin have been assigned pregnancy category C by the FDA (fetal risk is not confirmed by human studies but has been shown in some animal studies). Although not a first-line option for treatment of UTI in pregnancy, in certain clinical situations the benefits of using a fluoroquinolone may outweigh the risks to the developing fetus.
Nitrofurantoin is safe and effective; however, poor tissue penetration has limited its use in pyelonephritis. In the past, nitrofurantoin was completely avoided in the third trimester because of hemolytic effects on the newborn. Currently, restriction of this agent is limited to the last several weeks of pregnancy. Use during this period can cause hemolytic anemia in the fetus or neonate as a consequence of their immature erythrocyte enzyme systems (glutathione instability). Nitrofurantoin is also safe and effective for once-daily prophylactic therapy during pregnancy. [25]
Tetracyclines (adverse effects on fetal teeth and bones and congenital defects)
Trimethoprim in the first trimester (facial defects and cardiac abnormalities)
Chloramphenicol (gray syndrome)
Sulfonamides in the third trimester (hemolytic anemia in mothers with glucose-6-phosphate dehydrogenase [G6PD] deficiency, jaundice, and kernicterus)
Cesarean delivery is associated with UTI (increasing the likelihood 2.7-fold), but this association may be confounded by bladder catheterization or prolonged rupture of membranes (PROM). The incidence of symptomatic UTI is 9.3%, and that of asymptomatic bacteriuria is 7.6%.
Patients with pyelonephritis have fever (usually >38°C), flank tenderness upon palpation, and an ill appearance. Flank tenderness occurs on the right side in more than half of patients, bilaterally in one fourth, and on the left side in one fourth. Pain may also be found suprapubically with palpation.
Urinalysis, gram stain and culture/susceptibility tests should be done. Blood cultures are not routinely done unless septic. Ultrasound of KUB reserved for failure to respond to treatment.
Indications for admission: pre-term labor and other indications as listed above for acute uncomplicated pyelonephritis. Switch to oral regimen when afebrile x 48 hrs. and based on culture/susceptibility result. Recommended duration of treatment is 14d. Test of cure with a urine culture post-treatment is essential. Follow up with monthly urine culture until delivery.
Cesarean delivery is associated with UTI (increasing the likelihood 2.7-fold), but this association may be confounded by bladder catheterization or prolonged rupture of membranes (PROM). The incidence of symptomatic UTI is 9.3%, and that of asymptomatic bacteriuria is 7.6%.
Patients with pyelonephritis have fever (usually >38°C), flank tenderness upon palpation, and an ill appearance. Flank tenderness occurs on the right side in more than half of patients, bilaterally in one fourth, and on the left side in one fourth. Pain may also be found suprapubically with palpation.
to ensure good hygiene and reduce bacterial contamination of the urethral meatus, thereby preventing inadequate treatment and recurrent infection
Down to the
In addition to receiving ARVs, all HIV positive pregnant women are scheduled for an elective CS.
The POGS clinical guidelines on HIV recommends cesarean delivery at completed 38 weeks age of gestation.
If there is spontaneous rupture of amniotic bag of less than 4 hours, perform an emergency cesarean section, unless delivery is imminent.
A longer duration of ruptured membranes may be associated with a higher rate of mother-to-child transmission
risk of vertical transmission increased by 2% for every increase of 1 hour in the duration of ruptured membranes (International Perinatal HIV group meta-analysis)
Vaginal delivery may be performed when the risk of mother-to-child transmission of HIV is low as in the following situations:
In those who received anti-HIV medications during pregnancy and
have a viral load less than 1,000 copies/mL near the time of delivery and
if membranes rupture, the time elapsed should not be more than 4 hours to delivery.
Down to the
Engage in talk with Helen
Is HBsAg done twice- on first PNC and then at time of admission … routinely?
HBsAg reactive what is usual course of action (i.e. get quantitative HBs Ag, get panel, refer to Gastro or ID?)
The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations
Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5)
This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD.
In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details).
The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations
Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5)
This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD.
In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details).
TDF is the preferred choice owing to its antiviral potency and concerns for resis- tance with the other antiviral agents.
With discontinuation of treatment, women should be monitored for ALT flares every 3 months for 6 months.
Interim studies show high efficacy of TDF in preventing mother-to-child transmission.
Guidance: TAF has not been studied in pregnant women and no data have been reported to the anti-retroviral registry regarding the safety of TAF in pregnancy. Thus, there are insufficient data to recommend use of TAF in pregnancy.
The CDC and ACIP’s updated guidance reflects the best currently available evidence and select new or updated recommendations
Published evidence indicates that maternal antiviral therapy during pregnancy further reduces perinatal HBV transmission (2,3,4,5)
This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization and Emerging Infections Expert Work Group in collaboration with Brenna L. Hughes, MD.
In addition to those highlighted above, there are also new recommendations regarding postvaccination serologic testing of infants born to HBsAg-positive mothers and revaccination for those not responding to initial vaccination (see CDC’s MMWR for details).
Hepatitis B vaccine is administered IM in 3 doses at 0,1,6-12 months.
The accelerated schedule should be given in 4 doses at 0,1, 2, 12 months.
The rapid schedule should be given in 4 doses at 0, 7, 21 days and 12 months.
Most persons who acquire HPV clear the infection spontaneously and have no associated health problems. When the HPV infection does not clear, genital warts, precancers, and cancers of the cervix, anus, penis, vulva, vagina, head and neck might develop.
Most persons who acquire HPV clear the infection spontaneously and have no associated health problems. When the HPV infection does not clear, genital warts, precancers, and cancers of the cervix, anus, penis, vulva, vagina, head and neck might develop.
Lifetime number of sexual partners ≥6
Lifetime number of sexual partners ≥6
First full term pregnancy ≤17 years
All pregnant women should be screened for syphilis early in pregnancy.
U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults- U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008 Jul 1. 149(1)-43-7. [Medline].
Give the same dose as in non-pregnant women appropriate for the stage of syphilis.
Some evidence suggests that additional therapy is beneficial for pregnant women. For women who have primary, secondary, or early latent syphilis, a second dose of benzathine penicillin 2.4 million units IM can be administered 1 week after the initial dose.
No data are available to suggest that corticosteroid treatment alters the risk for treatment-related complications in pregnancy.
Tetracycline and doxycycline are contraindicated in the second and third trimester of pregnancy (317). Erythromycin and azithromycin should not be used, because neither reliably cures maternal infection or treats an infected fetus (444). Data are insufficient to recommend ceftriaxone for treatment of maternal infection and prevention of congenital syphilis.